Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.

Pridgeon, CSSchlott, CWong, MWHeringa, MBHeckel, TLeedale, JLaunay, LGryshkova, VPrzyborski, Setal2025-03-262025-03-2620182936286310.1007/s00204-018-2152-9https://rivm.openrepository.com/handle/10029/651034Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.ArticleArch Toxicol 2018; 92(2):557-692025-03-26